CDG THERAPEUTICS INC has a total of 36 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Singapore, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are NEUTEC PHARMA PLC, ST VINCENTS INSTITUTE OF MEDICAL RES and SILER-KHODR THERESA M.
# | Country | Total Patents | |
---|---|---|---|
#1 | Singapore | 6 | |
#2 | Canada | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Israel | 5 | |
#5 | Australia | 4 | |
#6 | Republic of Korea | 4 | |
#7 | WIPO (World Intellectual Property Organization) | 4 | |
#8 | China | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Climate change adaptation technologies | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Das Gupta Tapas | 24 |
#2 | Beattie Craig | 19 |
#3 | Mehta Rajeshwari | 11 |
#4 | Yamada Tohru | 10 |
#5 | Mehta Rajendra G | 7 |
#6 | Tapas Das Gupta | 7 |
#7 | Craig Beattie | 7 |
#8 | Taylor Brad | 6 |
#9 | Chakrabarty Ananda | 5 |
#10 | Rajeshwari Mehta | 4 |
Publication | Filing date | Title |
---|---|---|
AU2010249705A1 | Compositions and methods to prevent cancer by stabilizing p53 through non MDM2-mediated pathways | |
SG174136A1 | Compositions and methods to prevent and/or treat cancer with pa -card | |
KR20110128878A | Modifications of cupredoxin derived peptides and methods of use thereof | |
AU2009335846A1 | Compositions and methods to prevent cancer with cupredoxins | |
KR20110126595A | Compositions and methods to prevent cancer with cupredoxins | |
WO2009078977A2 | Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins |